Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other Oncogenes

Ipsita Pal, PhD, Yu Ri Kim, MD, Sohani Das Sharma, PhD, Prabhjot S. Mundi, MD, Andre M. Grilo, PhD, Luke E Berchowitz, PhD, Mingzhao Zhu, PhD, Hull G. Kenneth, PhD, Daniel Romo, PhD, Owen O'Connor, MD PhD, Marko Jovanovic, PhD, Changchun Deng, MD PhD

Blood (2019) 134 (Supplement_1): 4067.

https://doi.org/10.1182/blood-2019-131816

Published: 2019

Journal Articles

Harnessing Invariant Natural Killer T Cells for Cancer Therapy

Madhav V. Dhodapkar, MD

Blood (2012) 120 (21): SCI-20.

https://doi.org/10.1182/blood.V120.21.SCI-20.SCI-20

Published: 2012

Journal Articles

Agelastatin A (AgA), a Marine Sponge Derived Alkaloid, Inhibits Wnt/Beta-Catenin Signaling and Selectively Induces Apoptosis in Chronic Lymphocytic Leukemia Independently of p53

Michael Y. Choi, MD, Johanna Melo Cardenas, BSc, Desheng Lu, MD, PhD, Jian Yu, PhD, E. Paige Stout, PhD, Raymond P. Wu, Ph.D., John M Horton, B.S., Allison Gomez, Julio A. Diaz-Perez, M.D., M.S., Dennis A. Carson, M.D., Tadeusz F. Molinski, PhD, Thomas J. Kipps, M.D., Ph.D, Januario E. Castro, M.D.

Blood (2011) 118 (21): 1786.

https://doi.org/10.1182/blood.V118.21.1786.1786

Published: 2011

Journal Articles

Inhibition of Chronic Myelogenous Leukemia Stem Cells with Novel Wnt Antagonists.

Edward Kavalerchik, MD, Jason Gotlib, MD MS, Ifat Geron, MS, Annelie Abrahamsson, MS, Wolfgang Wrasidlo, PhD, Daniel Goff, BS, Desheng Lu, PhD, Ted Molinski, PhD, Francis Giles, MD, Irving Weissman, MD, Dennis Carson, MD, Catriona Jamieson, MD PhD

Blood (2006) 108 (11): 238.

https://doi.org/10.1182/blood.V108.11.238.238

Published: 2006

Journal Articles

Human natural killer T cells acquire a memory-activated phenotype before birth

Hans J. J. van der Vliet, Nobusuke Nishi, Tanja D. de Gruijl, B. Mary E. von Blomberg, Alfons J. M. van den Eertwegh, Herbert M. Pinedo, Giuseppe Giaccone, Rik J. Scheper

Blood (2000) 95 (7): 2440–2442.

https://doi.org/10.1182/blood.V95.7.2440

Published: 2000

NARROW

Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other Oncogenes

Harnessing Invariant Natural Killer T Cells for Cancer Therapy

Agelastatin A (AgA), a Marine Sponge Derived Alkaloid, Inhibits Wnt/Beta-Catenin Signaling and Selectively Induces Apoptosis in Chronic Lymphocytic Leukemia Independently of p53

Inhibition of Chronic Myelogenous Leukemia Stem Cells with Novel Wnt Antagonists.

Human natural killer T cells acquire a memory-activated phenotype before birth

Email alerts

ASH Publications

American Society of Hematology

Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other Oncogenes

Harnessing Invariant Natural Killer T Cells for Cancer Therapy

Agelastatin A (AgA), a Marine Sponge Derived Alkaloid, Inhibits Wnt/Beta-Catenin Signaling and Selectively Induces Apoptosis in Chronic Lymphocytic Leukemia Independently of p53

Inhibition of Chronic Myelogenous Leukemia Stem Cells with Novel Wnt Antagonists.

Human natural killer T cells acquire a memory-activated phenotype before birth

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only